Herrod H G
Crippled Children's Foundation Research Center, University of Tennessee, Memphis 38103.
Allergy Proc. 1994 Nov-Dec;15(6):309-12. doi: 10.2500/108854194778816445.
Although intravenous immunoglobulin (IVIG) has primarily been recognized as useful in patients with antibody deficiencies, it continues to be used for an ever-expanding list of conditions. In addition to antibody replacement, IVIG may act as an immune modulator in certain autoimmune and inflammatory conditions. Its use should be carefully weighed against the high cost of the product. In conditions where it appears to be useful, controlled studies are necessary to prove its efficacy and its cost benefits.
尽管静脉注射免疫球蛋白（IVIG）主要被认为对抗体缺乏患者有用，但它仍被用于越来越多的病症。除了抗体替代作用外，IVIG在某些自身免疫性和炎性病症中可能起到免疫调节剂的作用。其使用应与该产品的高成本进行仔细权衡。在看似有用的情况下，需要进行对照研究以证明其疗效和成本效益。
